The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Reanalysis of the efficacy of molecular targeted agents (MTAs) given in the randomized trial SHIVA01 according to the ESMO ESCAT scale of actionability.
 
Aurelie Moreira
No Relationships to Disclose
 
Sophie Vacher
No Relationships to Disclose
 
Claire Morel
No Relationships to Disclose
 
Charlotte Lecerf
No Relationships to Disclose
 
Maxime Frelaut
No Relationships to Disclose
 
Marie Paule Sablin
No Relationships to Disclose
 
Delphine Loirat
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Roche
 
Francesco Ricci
No Relationships to Disclose
 
Segolene Hescot
No Relationships to Disclose
 
Edith Borcoman
No Relationships to Disclose
 
Nouritza Torossian
No Relationships to Disclose
 
Julien Masliah-Planchon
No Relationships to Disclose
 
Celine Callens
No Relationships to Disclose
 
Nicolas Servant
No Relationships to Disclose
 
Anne Vincent- Salomon
Honoraria - AstraZeneca; ROCHE
Research Funding - NanoString Technologies (Inst)
Travel, Accommodations, Expenses - NanoString Technologies; Roche/Genentech
 
Ivan Bieche
No Relationships to Disclose
 
Christophe Le Tourneau
Honoraria - Bristol-Myers Squibb; Merck Serono; MSD; Nanobiotix; Novartis; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Merck Serono; MSD; Nanobiotix; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD
 
Maud Kamal
No Relationships to Disclose